Other substances

Rifabutin

A broad spectrum antibiotic.

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Used to treat other disease

1
 Supporting references
0
 Contradictory references
0
 AI-suggested references
0
 Clinical trials

General information

Rifabutin on PubChem

Marketed as

ANSATIPIN; ANSATIPINE; MYCOBUTIN; RIFABUTIN; RIBUTIN

 

Structure image - Rifabutin

C[C@H]1/C=C/C=C(\C(=O)N=C2C(=C3C(=C4C2=NC5(N4)CCN(CC5)CC(C)C)C6=C(C(=C3O)C)O[C@@](C6=O)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)O)/C

Supporting references

Link Tested on Impact factor Notes Publication date
Prediction of potential inhibitors for RNA-dependent RNA polymerase of SARS-CoV-2 using comprehensive drug repurposing and molecular docking approach
RdRpol Small molecule In silico 		in silico 5.16

Predicted to bind the SARS-CoV-2 RNA-dependent RNA polymerase.

 Sep/17/2020
Export (.csv)